Avalon Executive VP of Product Jason Bush, Ph.D., MBA, Discusses the History And Challenges of Rare Disease Genetic Testing
The Human Genome Project has greatly contributed to our understanding of human biology. It has led to the development of various technologies that can measure DNA sequences and help identify missing parts of DNA. This technology has significantly increased our ability to measure what we can and want to measure, and has also reduced the cost of measurement over the last two decades.
In this article, Jason Bush, Avalon EVP of Product, discusses the rapid growth of genetic testing and the challenges it poses for the rare disease community, clinicians, and payers.
Read more at First Report Managed Care.
